José López‐Miranda

“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”

Marta Entrenas Castillo, Luis Manuel Entrenas Costa, José Manuel Vaquero Barrios et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2020 · 756 citations · Full text

Critical Care Management, Clinical Management, Critical Care Medicine +9

Intestinal Microbiota Is Influenced by Gender and Body Mass Index

Carmen Haro, Oriol Alberto Rangel-Zúñiga, Juan F. Alcalá‐Díaz et al. · PLoS ONE · 2016 · 679 citations · Full text

Dysbiosis, Host-microbe Interactions, Gastroenterology +21

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

Robert P. Giugliano, Terje R. Pedersen, Jeong-Gun Park et al. · The Lancet · 2017 · 658 citations

Cardiovascular Disease, Pcsk9 Inhibitor Evolocumab, Pharmacology +9

Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial

Javier Delgado‐Lista, Juan F. Alcalá‐Díaz, José D. Torres‐Peña et al. · The Lancet · 2022 · 534 citations

Nutrition, Lifestyle Modification, Cardiovascular Disease +9

Olive oil and health: Summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008

José López‐Miranda, Francisco Pérez‐Jiménez, Emilio Ros et al. · Nutrition Metabolism and Cardiovascular Diseases · 2010 · 511 citations

Nutrition, Nutritional Epidemiology, Dietary Exposure +12